Clinical Trial Update: Long-term Open-Label Safety Study to Evaluate EN3409 [Phase 3]

View source ↗

Summary

A long-term open-label safety study of EN3409 in Phase 3 has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Neuropathic Pain
• Osteoarthritis

Drugs mentioned

• EN3409

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Low Back Pain, Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-12